Summary
The drug looks for high amounts of reactive oxygen molecules, which are common in tumor cells, to turn on.
Laboratory tests on breast cancer cells and tiny fish showed it killed cancer cells while sparing healthy ones.
Key Points
4 points1
RK-251 stays inactive in normal tissue and activates in cancer cells.
2
It releases a compound named NBDHEX that blocks proteins cancer cells need to survive.
3
Tests on triple‑negative breast cancer cells showed strong killing power.
4
The medicine is still in early research and not yet tested in humans.
New Words to Learn
6 wordstumor
a lump of cells that grow too fast and can be harmful
triple‑negative breast cancer
a tough kind of breast cancer that does not have three common markers
NBDHEX
a special chemical that stops cancer cells from using important proteins
Institute of Advanced Study in Science and Technology
a research centre in India that studies new science ideas
Department of Science and Technology
the Indian government group that supports scientific research
Indian Institute of Technology
a top engineering and science university in India
Want to learn even more? Click here to read the full story!
🔊 Reading Article
Kid-friendly voice